what type of glp is tirzepatide Plano | Medical Weight Loss | TMRW Health The dual agonist action of
Description
Key points Real-world studies show high discontinuation rates for glucagon-like peptide 1 receptor agonists (GLP1RAs) and tirzepatide, particularly among individuals without type 2 diabetes mellitus who are using these drugs to treat obesity
Eli Lilly offers the Zepbound Savings Card for eligible commercially insured patients

This includes the initial consultation fee and the medication itself

[DOI] [PMC free article] [PubMed] [Google Scholar] 43.Riccio A, Ahn S, Davenport CM, Blendy JA, Ginty DD

ZEPBOUND (tirzepatide) is a new medication designed to help with weight management by targeting two specific receptors in the body, GIP and GLP-1

NICE is currently appraising the clinical and cost-effectiveness of tirzepatide within its marketing authorisation for managing obesity or overweight with risk factors
